{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:11:41Z","timestamp":1789445501666,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","award":["1708\/09"],"award-info":[{"award-number":["1708\/09"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","award":["1708\/09"],"award-info":[{"award-number":["1708\/09"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","award":["1708\/09"],"award-info":[{"award-number":["1708\/09"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","award":["1708\/09"],"award-info":[{"award-number":["1708\/09"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","award":["1708\/09"],"award-info":[{"award-number":["1708\/09"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002089","name":"Fight for Sight","doi-asserted-by":"publisher","award":["1708\/09"],"award-info":[{"award-number":["1708\/09"]}],"id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41433-019-0493-0","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T12:04:56Z","timestamp":1560945896000},"page":"1776-1783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Management of primary pterygium with intra-lesional injection of 5 flurouracil and bevacizumab (Avastin)"],"prefix":"10.1038","volume":"33","author":[{"given":"Noha","family":"Ghoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia G.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder S.","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"493_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.exer.2015.01.010","volume":"142","author":"KW Kim","year":"2016","unstructured":"Kim KW, Park SH, Kim JC. Fibroblast biology in pterygia. Exp Eye Res. 2016;142:32\u20139.","journal-title":"Exp Eye Res"},{"key":"493_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3892\/ijmm_00000149","volume":"23","author":"ET Detorakis","year":"2009","unstructured":"Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (Review). Int J Mol Med. 2009;23:439\u201347.","journal-title":"Int J Mol Med"},{"key":"493_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/ICO.0b013e31818d382d","volume":"28","author":"CC Teng","year":"2009","unstructured":"Teng CC, Patel NN, Jacobson L. Effect of subconjunctival bevacizumab on primary pterygium. Cornea. 2009;28:468\u201370.","journal-title":"Cornea"},{"key":"493_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/08820530902801106","volume":"24","author":"J Mauro","year":"2009","unstructured":"Mauro J, Foster CS. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment. Semin Ophthalmol. 2009;24:130\u20134.","journal-title":"Semin Ophthalmol"},{"key":"493_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.preteyeres.2004.02.002","volume":"23","author":"N Di Girolamo","year":"2004","unstructured":"Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res. 2004;23:195\u2013228.","journal-title":"Prog Retin Eye Res"},{"key":"493_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/bjophthalmol-2012-301944","volume":"98","author":"K Gumus","year":"2014","unstructured":"Gumus K, Karakucuk S, Mirza GE, Akgun H, Arda H, Oner AO. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate. Br J Ophthalmol. 2014;98:796\u2013800.","journal-title":"Br J Ophthalmol"},{"key":"493_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/eye.2012.194","volume":"26","author":"S Ling","year":"2012","unstructured":"Ling S, Li Q, Lin H, Li W, Wang T, Ye H, et al. Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium. Eye. 2012;26:1451\u20138.","journal-title":"Eye"},{"key":"493_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0955-0674(02)00361-7","volume":"14","author":"P Bornstein","year":"2002","unstructured":"Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol. 2002;14:608\u201316.","journal-title":"Curr Opin Cell Biol"},{"key":"493_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/eye.1993.146","volume":"7","author":"P Riordan-Eva","year":"1993","unstructured":"Riordan-Eva P, Kielhorn I, Ficker LA, Steele AD, Kirkness CM. Conjunctival autografting in the surgical management of pterygium. Eye. 1993;7:634\u20138.","journal-title":"Eye"},{"key":"493_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ophtha.2011.08.002","volume":"119","author":"A Kheirkhah","year":"2012","unstructured":"Kheirkhah A, Hashemi H, Adelpour M, Nikdel M, Rajabi MB, Behrouz MJ. Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft. Ophthalmology. 2012;119:227\u201332.","journal-title":"Ophthalmology"},{"key":"493_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/eye.2013.135","volume":"27","author":"DG Said","year":"2013","unstructured":"Said DG, Faraj LA, Elalfy MS, Yeung A, Miri A, Fares U, et al. Intra-lesional 5 fluorouracil for the management of recurrent pterygium. Eye. 2013;27:1123\u20139.","journal-title":"Eye"},{"key":"493_CR12","first-page":"559","volume":"66","author":"S Malik","year":"2016","unstructured":"Malik S, Khan MS, Basit I. Comparison of primary versus recurrent pterygium after intralesional 5-Fluorouracil. J Pak Med Assoc. 2016;66:559\u201362.","journal-title":"J Pak Med Assoc"},{"key":"493_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10792-013-9852-1","volume":"34","author":"SA Bayar","year":"2014","unstructured":"Bayar SA, Kucukerdonmez C, Oner O, Akova YA. Subconjunctival bevacizumab in the impending recurrent pterygia. Int Ophthalmol. 2014;34:541\u20137.","journal-title":"Int Ophthalmol"},{"key":"493_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1089\/jop.2014.0060","volume":"31","author":"A Nava-Casta\u00f1eda","year":"2015","unstructured":"Nava-Casta\u00f1eda A, Ulloa-Orozco I, Garnica-Hayashi L, Hernandez-Orgaz J, Jimenez Martinez MC, Garfias Y. Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up. J Ocul Pharmacol Ther. 2015;31:106\u201313.","journal-title":"J Ocul Pharmacol Ther"},{"key":"493_CR15","first-page":"130","volume":"32","author":"MS Khan","year":"2016","unstructured":"Khan MS, Malik S, Basit I. Effect of intralesional 5 fluorouracil injection in primary pterygium. Pak J Med Sci. 2016;32:130\u20133.","journal-title":"Pak J Med Sci"},{"key":"493_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.4103\/0301-4738.171508","volume":"63","author":"P Singh","year":"2015","unstructured":"Singh P, Sarkar L, Sethi HS, Gupta VS. A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients. Indian J Ophthalmol. 2015;63:779\u201384.","journal-title":"Indian J Ophthalmol"},{"key":"493_CR17","first-page":"179","volume":"49","author":"MR Besharati","year":"2011","unstructured":"Besharati MR, Manaviat MR, Souzani A. Subconjunctival bevacizumab injection in treatment of pterygium. Acta Med Iran. 2011;49:179\u201383.","journal-title":"Acta Med Iran"},{"key":"493_CR18","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/sj.eye.6702433","volume":"21","author":"JK Lee","year":"2007","unstructured":"Lee JK, Song YS, Ha HS, Park JH, Kim MK, Park AJ. Endothelial progenitor cells in pterygium pathogenesis. Eye. 2007;21:1186\u201393.","journal-title":"Eye"},{"key":"493_CR19","first-page":"797","volume":"11","author":"TA Mohamed","year":"2018","unstructured":"Mohamed TA, Soliman W, Fathalla AM, El Refaie A. Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study. Int J Ophthalmol. 2018;11:797\u2013801.","journal-title":"Int J Ophthalmol"},{"key":"493_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00417-003-0846-y","volume":"242","author":"W Naib-Majani","year":"2004","unstructured":"Naib-Majani W, Eltohami I, Wernert N, Watts W, Tschesche H, Pleyer U. Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study. Graefes Arch Clin Exp Ophthalmol. 2004;242:332\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"493_CR21","first-page":"2127","volume":"43","author":"C Cursiefen","year":"2002","unstructured":"Cursiefen C, Schl\u00f6tzer-Schrehardt U, K\u00fcchle M, Breiteneder-Geleff S, Alitalo K, Jackson D. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci. 2002;43:2127\u201335.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"493_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1167\/iovs.13-13453","volume":"55","author":"SL Schlereth","year":"2014","unstructured":"Schlereth SL, Neuser B, Caramoy A, Grajewski RS, Koch KR, Schr\u00f6dl F, et al. Enrichment of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1)-positive macrophages around blood vessels in the normal human sclera. Invest Ophthalmol Vis Sci. 2014;55:865\u201372.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"493_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3892\/ijmm_00000371","volume":"25","author":"ET Detorakis","year":"2010","unstructured":"Detorakis ET, Zaravinos A, Spandidos DA. Growth factor expression in ophthalmic pterygia and normal conjunctiva. Int J Mol Med. 2010;25:513\u20136.","journal-title":"Int J Mol Med"},{"key":"493_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0065-1281(89)80035-2","volume":"87","author":"Y Dake","year":"1989","unstructured":"Dake Y, Mukae R, Soda Y, Kaneko M, Amemiya T. Immunohistochemical localization of collagen types I, II, III, and IV in pterygium tissues. Acta Histochem. 1989;87:71\u20134.","journal-title":"Acta Histochem"},{"key":"493_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/bjo.2007.115709","volume":"91","author":"S Kase","year":"2007","unstructured":"Kase S, Osaki M, Sato I, Takahashi S, Nakanishi K, Yoshida K, et al. Immunolocalisation of E-cadherin and beta-catenin in human pterygium. Br J Ophthalmol. 2007;91:1209\u201312.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0493-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0493-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0493-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:36Z","timestamp":1684616856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0493-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0493-0","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"assertion":[{"value":"8 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}